The acute phase response (APR) induces alterations in lipid metabolism and our data suggest that this is associated with suppression of type II nuclear hormone receptors that are key regulators of fatty acid, cholesterol and bile acid metabolism. Recently, the farnesoid X receptor (FXR), constitutive androstane receptor (CAR) and pregnane X receptor (PXR) were found to regulate DHEA sulfotransferase (Sult2A1), which plays an important role in DHEA sulfation and detoxification of bile acids. Since FXR, PXR, and CAR are suppressed during the APR, we hypothesized that Sult2A1 is downregulated during the APR. To induce the APR, mice were treated with LPS that will then trigger the release of various cytokines and the mRNA levels of Sult2A1 and the sulfate donor, 3'-phosphoadenosine 5'-phosphosulfate synthase 2 (PAPSS2), as well as the enzyme activity of Sult2A1, was determined in the liver. We found that mRNA levels of Sult2A1 decrease in a time-and dose-dependent manner during the LPS-induced APR.
INTRODUCTION
Sulfotransferase (Sult) enzymes catalyze the transfer of a sulfate group from the universal sulfonate (SO 3 ) donor 3'-phosphoadenosine 5'-phosphosulfate (PAPS) to a wide range of endogenous molecules ranging from neurotransmitters and hormones to xenobiotic compounds (56) . Upon the addition of the highly charged sulfonate group, compounds undergo major changes in their physicochemical properties. Sulfonation increases water solubility, converting lipophilic molecules to amphiphiles that remain ionized in solution. As one of the prominent conjugating systems, sulfonation, together with phosphorylation, is essential for normal growth and development, catalyzing an important modification for macromolecules such as proteoglycans and glycosaminoglycans (24, 41) , for tyrosine residues of many secretory and membrane proteins and peptides (25, 42) , and for sulfoglycolipids such as sphingolipids and galactoglycerolipids (59) . Cholesterol and its derivatives (27), bile acids (45), and steroids (12) undergo sulfonation as part of their normal metabolism.
There are two classes of sulfotransferase based on their solubility. Membrane-associated insoluble sulfotransferases are located in trans-Golgi complex, where they are involved in the posttranslational modification of macromolecules (56) . Soluble or cytosolic sulfotransferases sulfonate various endogenous compounds including hormones and neurotransmitters, drugs and xenobiotics. In mammals, cytosolic sulfotransferases comprise five Sult families with ~40% similarity in amino acid sequences. The Sult1 family transfers sulfonate to catecholamines, estrogenic steroids, thyroid hormones, phenolic drugs and xenobiotics. The Sult2 family mainly sulfonates neutral steroids and sterols. The Sult3 enzymes catalyze the formation of sulfamates whereas Sult4 and Sult5 have not yet been characterized. Dehydroepiandrosterone (DHEA) sulfotransferase (Sult2A1) catalyzes sulfonation of a number of endogenous hydroxysteroids, and bile acids as well as polycyclic xenobiotics such as certain aromatic carcinogens (30, 44) . The substrates of this Sult2A1 include dehydroepiandrosterone (DHEA), which has been suggested to be a multifunctional hormone with immuno-enhancing, anti-cancer, neurotropic and anti-aging effects (57) . Sult2A1 catalyzes conversion of DHEA to DHEA sulfate (DHEA-S), but the physiological significance of this event is not well understood. The serum concentration of DHEA-S is 300-500 times higher than that of DHEA and 20 times higher than that of any other steroid hormone (3) . Whereas DHEA-S is bound to albumin and forms a circulating reservoir, DHEA has been reported to be more active at the tissue level (3) . Only lipophilic DHEA can be converted intracellularly to androgens and estrogen and the biosynthesis of all sex steroids in human proceeds through DHEA. Because only the unconjugated steroid hormone DHEA has growth-promoting activity, changes in the regulation of Sult2A1 activity could be implicated in a variety of physiological states and pathophysiological disorders (3).
Also, sulfation of the toxic bile acid lithocholic acid (LCA) by Sult2A1 increases water solubility, decreases reabsorption, and facilitates the clearance of LCA (46). Therefore, sulfation of LCA protects liver from its toxicity-induced cholestasis (60) .
Transcription of Sult2A1 has been shown to be regulated by type II nuclear hormone receptors farnesoid X receptor (FXR) (53), Constitutive Androstane Receptor (CAR) and pregnane X receptor (PXR) (55) . FXR is involved in the homeostasis of bile acid synthesis from cholesterol and bile acid transport. The primary bile acid chenodeoxycholic acid (CDCA), which is the most potent ligand for FXR, strongly increases the mRNA level of Sult2A1 through an inverted repeat-0 (IR-0) cognate to FXR/RXRα response element (53). PXR has also been shown to regulate Sult2A1. PXR regulates genes involved in the detoxification of xenobiotics and activation of PXR induces the transcription of target genes that encode oxidative cytochrome p450 enzymes and drug transporters (7) (8) (9) 29 (48) showed that Sult2A1 is also regulated by CAR.
Therefore, altered activity of FXR/RXRα, CAR/RXRα and/or PXR/RXRα under pathological conditions could lead to changes in the mRNA levels of Sult2A1 and PAPSS2, regulating the metabolism of hydroxysteroids and bile acids.
Since activities of PXR (6), CAR (6) , and FXR (28) together with their heterodimer partner RXRα are significantly suppressed during the APR, we hypothesized that mRNA level and enzyme activity of Sult2A1 would be also down-regulated. If so, this change could contribute to the decrease in DHEA-S seen during infection and in inflammatory diseases such as rheumatoid arthritis and arteritis (43) . To test this hypothesis, we chose C57BL/6 mice as an experimental model because of their high circulating levels of DHEA-S compared to those of other rodents (38) and treated them with very low doses of lipopolysaccharide (LPS), an inducer of APR. Our results demonstrate that the mRNA levels of Sult2A1 and PAPSS2 are dramatically decreased in mouse liver during the LPS-induced APR. Furthermore, we demonstrate that the LPS-induced decrease in Sult2A1 mRNA levels was accompanied by a significant reduction in its activity and in circulating levels of DHEA-S. Our present study provides a possible mechanism for the changes in the sulfation of hydroxysteroids and bile acids observed during the APR. [1, 2, 6, H(N)]-dehydroepiandrosterone (DHEA) was purchased from PerkinElmer Life Sciences, Inc (Boston, MA). DHEA, 3'-phosphoadenosine 5'-phosphosulfate (PAPS), and the PXR agonist pregnenolone-16α-carbonitrile (PCN) were purchased from Sigma.
MATERIALS and METHODS

Materials -
Animals -All animal experimentation described in the present study was conducted in accord with accepted standards of humane animal care. Eight-week-old female C57BL/6 mice were purchased from Jackson Laboratory. Only female mice were used in the present study because Preparation of cytosolic extract from mouse liver-Fresh mouse liver was collected into glass tubes and homogenized in buffer containing 250 mM sucrose, 5mM HEPES, 2mM 2-mercaptoethanol, pH 7.4. Homogenates were centrifuged at 11,000 g for 2 min. The resulting supernatants were centrifuged for 30 min at 105, 000 g, and the cytosolic fractions (supernatants)
were stored in small aliquots at -70 °C until use.
Estimation of protein-Protein content of hepatic cytosolic extract was estimated using Bio-Rad protein quantitation reagent with bovine serum albumin as standard. mM Tris/HCl, pH 8.7 and 3 mL chloroform were added and the tubes were shaken vigorously before centrifugation at 3,000 g for 5 min. 200 uL of the supernatant were mixed with 8 mL scintillation fluid and radioactivity was quantified by liquid scintillation spectrometry. The enzyme activity was expressed as % control.
Measurement of Sult2A1 enzyme activity-
RNA isolation and Northern Blot Analysis -Total RNA from mouse was isolated from 300 to 400 mg of snap-frozen whole liver tissue using Tri-Reagent (Sigma). Poly(A)+ RNA was subsequently purified using oligo(dT) cellulose. RNA was quantified by measuring absorption at 260 nm. 10 ug of poly(A)+ were denatured and electrophoresed on a 1%
agarose/formaldehyde gel. Total RNA from Hep3B was isolated from a 100 mm dish by the TriReagent method, and resuspended in DEPC-water. 30 µg of total RNA was denatured and electrophoresed as described above. The uniformity of RNA loading was checked by UV visualization of 18S and 28S bands on the ethidium bromide-stained gel before electrotransfer to Nytran membrane (Schleicher & Schuell). Prehybridization, hybridization and washing procedures were performed as described previously (36) . Membranes were probed with [α- 32 P] dCTP-labeled cDNAs using the random priming technique (Amersham Biosciences, UK).
mRNA levels were detected by exposure of the membrane to X-ray film and quantified by densitometry. House-keeping genes such as cylophilin D was used to confirm the equal amount of RNA loading. Sult2A1 and PAPSS2 probes were prepared by PCR using the following
Serum DHEA and DHEA-S Measurement -Serum concentrations of DHEA and DHEA-S were measured using the 125 I RIA kit by following the manufacturer's instruction (ICN).
Statistical Analysis -Data are expressed as mean ± S.E. of experiments from 3-5 animals or plates for each groups or time point. The difference between two experimental groups was analyzed using the Student's t-test. Differences among multiple groups were analyzed using one-way analysis of variance with the Bonferroni post hoc test. A p value < 0.05 was considered significant.
RESULTS
LPS adiminstration decreases Sult2A1 mRNA levels during the APR.
Initially, we determined the effect of LPS administration on the Sult2A1 mRNA level in mouse liver at various times up to 24 h. As shown in Figure 1A , LPS administration caused a significant decrease in the mRNA level of Sult2A1 as early as 4h following treatment (~50% of the control), which plateaued at 8h and persisted for at least 24h. Next, we determined if Sult2A1 mRNA decreases in a dose-dependent manner in response to LPS administration (Fig 1B) . Our preliminary studies indicated that mRNA level of Sult2A1 responds very sensitively with a dramatic reduction, when mice were treated with doses of LPS > 0.1 µg. Therefore, we tested a wide range of doses of LPS from 10 -4 to 10 2 µg/mouse. As shown in Figure 1B , statistically significant decrease in Sult2A1 mRNA was caused by a dose of 1 ng/mouse or higher and the maximal decrease was observed with a dose approximately 1 µg/mouse. Figure 1C shows that 100 ug of LPS did not affect GAPDH mRNA level in mouse liver, indicating that equal amounts of RNA were loaded and that the effect of LPS on Sult2A1 is specific. These data indicate that the LPS-induced decrease in Sult2A1 mRNA is highly sensitive and dose-dependent in mouse liver, with the half-maximal effect occurring at a dose <1 ng LPS/mouse.
It should be noted that the effect of LPS on the mRNA level of Sult2A1 is specific because LPS did not affect the mRNA level of cholesterol sulfotransferase (Sult2B1) (data not shown).
LPS administration decreases mRNA level of PAPSS2 in mouse liver. Since we observed that mRNA level of Sult2A1 is regulated during the APR, we next determined whether LPS administration also decreases mRNA level of PAPS synthase 2 (PAPSS2). This enzyme is primarily responsible for producing the sulfonate group donor PAPS in the liver and has been shown to be activated by PXR (55) . As shown in Figure 2A , as early as 2 h after administration, LPS caused a greater than 50% decrease in the mRNA level of PAPSS2. At 4 h after LPS administration, there was a more than 75% decrease (p<0.001), with further decreases at 8 h which persisted for a 24h period. These data indicate that PAPSS2 mRNA level rapidly decreased following LPS administration. The decrease in PAPSS2 mRNA after LPS administration was dose-dependent. As shown in figure 2B , LPS administration decreased PAPSS2 mRNA level with the half-maximal effect occurring at ~0.5 ng/mouse. All doses but the lowest tested in the experiment caused a significant reduction (p<0.005) in PAPSS2 mRNA levels in mouse liver.
LPS administration significantly decreases Sult2A1 activity in mouse liver homogenate.
Having observed a significant reduction in mRNA levels of both Sult2A1 and PAPSS2 in mouse liver, we hypothesized that reduced mRNA level of these genes would ultimately result in a decrease in Sult2A1 enzyme activity. As shown in Figure 3A , 16 hours after LPS administration, Sult2A1 activities in liver were significantly decreased by ~60% (p<0.01) when compared to that of the control mouse. This data clearly demonstrate that LPS-induced decrease in Sult2A1 mRNA level is associated with reduced level of hepatic Sult2A1 activity.
LPS administration significantly decreases the level of serum DHEA-S.
In mammals, DHEA is the primary substrate for sulfation reaction by Sult2A1 and altered sulfation status of DHEA could affect functionality of DHEA steroid hormones. Since Sult2A1 enzyme activity is downregulated in LPS-treated mouse liver as shown in Figure 3A , we next determined if these changes in Sult2A1 activity lead to reduced levels of serum DHEA-S. As shown in Figure 3B , 24 h after LPS administration serum DHEA-S levels are significantly decreased by 50 % when compared to control mice. Thus, decreased mRNA level of Sult2A1 is associated with reduction in enzyme activity and the circulating levels of DHEA-S during LPS-induced APR.
MRNA level of Sult2A1 is increased by PCN administration and inhibited by LPS administration.
Since Sult2A1 has been reported to be regulated by PXR (55) In the present study, we determined whether the mRNA level and activity of Sult2A1 are altered during LPS-induced APR in a rodent model. Here we demonstrate that LPS, an inducer of the APR, dramatically decreases the mRNA levels of both Sult2A1 and PAPSS2, an enzyme that synthesizes the sulfate donor PAPS in mouse liver. The inhibitory effect of LPS on the mRNA levels of these two enzymes occurred at very low doses; the mRNA levels of both Sult2A1 and PAPSS2 are significantly decreased at a dose of 1 ng LPS, making these changes among the most sensitive host responses to LPS. The mRNA levels of both genes demonstrate a similar time course but the mRNA level of PAPSS2 decreased earlier and remained at a lower level than that of Sult2A1 during the 24h period of study. We also show that these changes were accompanied by a decrease in the enzyme activity of Sult2A1. Furthermore, we show that the decrease in enzyme activity resulted in a significant reduction in the circulating level of DHEA-S, suggesting that there may be significant alterations in the sulfation of hydroxysteroids, drugs, Altered sulfation activity caused by decreased Sult2A1 expression could also affect drug metabolism during the APR. PXR coordinately regulate drug-metabolizing enzymes in the activation (Phase I) and conjugation/inactivation (Phase II) processes which include CYP3A and Sult2A1. It has been shown that the common drug acetaminophen is metabolized through PXRmediated glucuronidation and sulfation and that both of these processes are enhanced in rodent liver by PCN or dexamethasone treatment (51) . In the present study, we show that PCN increases Sult2A1 mRNA and activity and that simultaneous administration of LPS abolishes the induction caused by PCN. Similary, we have previously shown that another PXR ligand RU 486, which is a glucocorticoid antagonist, significantly increased mRNA level of the PXR target gene Cyp3A and this induction was abolished by LPS treatment (6) . Therefore, suppression of Sult2A1 together with Cyp3A could contribute to the altered drug metabolism during the APR.
Results from the present study may also help explain the LPS-induced impairment of bile flow and cholestasis (11) . LCA is a hydrophobic secondary bile acid that is primarily formed in the intestine by the bacterial dehydroxylation of chenodeoxycholic acid and has been related to intrahepatic cholestasis (15, 26) . Sulfation by Sult2A1 is important for detoxification of LCA as evidenced by a study in which non-sulfated LCA produced a marked cholestasis when introduced to animals, whereas sulfated LCA did not (33) In summary, we find that the mRNA level of Sult2A1 is significantly decreased during LPS-mediated APR in rodent liver. Also, the mRNA level of PAPSS2 was similarly downregulated, suggesting that the synthesis of sulfate donor molecule PAPS could be decreased. Effect of LPS on Sult2A1 activity C57BL/6 mice were injected IP with either saline or LPS (100 µg of LPS per mouse) and the animals were sacrificed at 16 h after LPS administration.
Cytosolic extract was prepared and used for the enzyme assay as described in "METHODS". (B)
Effect of LPS on serum DHEA-S C57BL/6 mice were injected IP with either saline or LPS (100 µg of LPS per mouse). The animals were sacrificed at 24h after LPS administration and the serum was collected for the DHEA-S assay using the 125 I RIA kit (ICN) as described in "METHODS". Data (means ± S.E., n =5) are expressed as a percentage of controls. *, p < 0.05 
